NRTIs in Development
New Tenofovir Prodrug Shows Potency, Plus Better Kidney and Bone Safety Than Current Formulation (March 7, 2013)
In The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), from TheBodyPRO.com
- An Overview of Racivir (November 2, 2012)
From AIDSinfo
- An Overview of Elvucitabine (October 31, 2012)
From AIDSinfo
Building a Better Tenofovir: Oral Prodrug GS-7340 Outperforms "Old" Tenofovir, Research Finds (October 26, 2012)
In The 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2012) , from TheBodyPRO.com
- An Overview of GS-7340 (October 24, 2012)
From AIDSinfo
- Merck Acquires CMX157 and EFdA and Starts Phase 2 Study for New NNRTI (September/October 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- In Vitro Resistance Profile for BMS 986001 (July 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- In Vitro and Animal Data Support Safety Profile BMS 986001: d4T-Like NRTI Currently in Clinical Trials (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Studies on Pipeline Antiretrovirals Reveal New Data on Possible Drug Interactions (May/June 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Avexa Reaches Agreement With U.S. Regulator (March 31, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
VIEW ALL ARTICLES
|
Advertisement
|